Corticosteroids for Multiple Sclerosis: II. Application for Disease-Modifying Effects
✍ Scribed by Anjali Shah; Eric Eggenberger; Robert Zivadinov; Olaf Stüve; Elliot M. Frohman
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 81 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1933-7213
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Multiple sclerosis (MS) is an inflammatory demyelinating disorder characterized by a multiphasic course of neurological exacerbations, periods of clinical remission, and, in most patients, ultimately progressive deterioration of functional capabilities. The relapsing-remitting phase of the disease i
## Abstract The rational development of disease‐modifying therapies for multiple sclerosis (MS) requires a detailed knowledge of disease pathogenesis, but this remains incomplete. Dynamic computer‐assisted modeling of MS is currently hindered by uncertainties about the connectivity, compartmentaliz